Press Kit

Company Profile

Corporate Profile

Technology Profile

CEO Profile

Scientific Founder Overview

News Releases

Magneceutical Health announcement, October 10, 2011

Pico-Tesla reports promising results in Fibromyalgia study, April 13 2011

Pico-Tesla receives ISO 13485:2003 certification, March 14, 2011

Pico-Tesla starts Alzheimer’s disease Study with University of South Florida (USF) Health Byrd Alzheimer’s Institute, Jan 5, 2011

Pico-Tesla expands Pivotal clinical trial for Parkinson’s disease, Jan 4, 2011

Pico-Tesla begins Pilot Study in Fibromyalgia, Dec 15, 2010

Pico-Tesla elects Jack Calderon to its Board, September 29, 2010

Pico-Tesla expands operations to the Midwest, August 26, 2010

Pico-Tesla's Magneceutical® Therapy featured in EP Lab Digest,
August 10, 2010

Electromagnetic fields can suppress atrial fibrillation, May 24, 2010

Dr. Bellido elected as Director of Pico-Tesla, May 10, 2010

Pico-Tesla Opens East Coast Headquarters, March 15, 2010

Phase III clinical trial of Magneceutical® therapy for Parkinson's Disease, October 5, 2009

Pilot Study, Parkinson's Disease, September 18, 2009


Videos

Corporate Video

Corporate Executives & Medical Professionals

Patients & Caregivers

 

 

Please Download the latest version of Adobe Flash Player.

 

ABOUT US

Our Team

Participate in our research
News Releases

Terms & Conditions of Use

 
 

 

 

 

 

 



 

 

 

 

 

 

 

   

 

 

 

 
 

4700 140th Ave. N., Suite 101 • Clearwater, FL 33762 • 727-474-3722

HOME | CONTACT US

 
 

The Resonator™ device is an Investigational Device limited by Federal (or United States)
law to investigational use. The Resonator™ device is not for sale, nor is the Magneceutical®
Therapy generally available outside of Investigational Review Board (IRB) approved clinical studies.